Fisher & Paykel Healthcare Corporation Limited (FSPKF) Stock Forecast & Price Target

Compare

59 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

FSPKF Analyst Ratings

Moderate Buy

4 Buy

3 Hold

1 Sell

Based on 8 analysts giving stock ratings to

Fisher

& Paykel Healthcare Corporation Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

FSPKF Stock 12 Month Forecast

Average Price Target

$24.69

▲(7.35% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Fisher & Paykel Healthcare Corporation Limited in the last 3 months. The average price target is $24.69 with a high forecast of $28.49 and a low forecast of $20.64. The average price target represents a 7.35% change from the last price of $23.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","22":"$22","29":"$29","18.5":"$18.5","25.5":"$25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28.49196,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$28.49</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.69,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.69</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.6367,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$20.64</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,18.5,22,25.5,29],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.43,21.05015076923077,21.670301538461537,22.290452307692306,22.910603076923078,23.530753846153846,24.150904615384615,24.771055384615384,25.391206153846152,26.011356923076924,26.631507692307693,27.25165846153846,27.87180923076923,{"y":28.49196,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.43,20.757692307692306,21.085384615384616,21.413076923076922,21.74076923076923,22.068461538461538,22.396153846153847,22.723846153846154,23.051538461538463,23.37923076923077,23.70692307692308,24.034615384615385,24.362307692307695,{"y":24.69,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.43,20.445899999999998,20.4618,20.4777,20.4936,20.5095,20.5254,20.5413,20.5572,20.5731,20.589000000000002,20.6049,20.620800000000003,{"y":20.6367,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.02,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":25.54,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.14,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":17.23,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":16.69,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.96,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.88,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.88,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.82,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.82,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.43,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$28.49

Average Price Target$24.69

Lowest Price Target$20.64

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Davinthra Thillainathan

Goldman Sachs

$28.49

Buy

23.88%

Upside

Reiterated

12/01/25

Goldman Sachs Reaffirms Their Buy Rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

David Bailey

Morgan Stanley

$23.5→$24.63

Buy

7.09%

Upside

Reiterated

11/26/25

Analysts Are Bullish on These Healthcare Stocks: Fisher & Paykel Healthcare Corporation Limited (FSPKF), 3SBio (TRSBF)

Shane Storey

Canaccord Genuity

$25.02

Buy

8.77%

Upside

Reiterated

11/26/25

Canaccord Genuity Sticks to Their Buy Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Laura Sutcliffe

Citi

―

Hold

―

Reiterated

11/26/25

Analysts Offer Insights on Healthcare Companies: Nyxoah (NASDAQ: NYXH) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)

Craig Wong-Pan

RBC Capital

$19.31→$20.64

Sell

-10.28%

Downside

Reiterated

11/26/25

RBC Capital Sticks to Its Sell Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Christine Trinh

Macquarie

―

Buy

―

Reiterated

11/26/25

Macquarie Sticks to Their Buy Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Adrian Allbon

Jarden

―

Hold

―

Reiterated

11/26/25

Jarden Keeps Their Hold Rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Marcus Curley

UBS

―

Hold

―

Reiterated

11/26/25

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)

David Low

J.P. Morgan

―

Hold

―

Reiterated

06/03/25

J.P. Morgan Sticks to Its Hold Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Vanessa Thomson

Jefferies

$23.83→$25.16

Buy

9.41%

Upside

Upgraded

05/28/25

Positive Report for Fisher & Paykel Healthcare Corporation Limited (FSPKF) from Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Davinthra Thillainathan

Goldman Sachs

$28.49

Buy

23.88%

Upside

Reiterated

12/01/25

Goldman Sachs Reaffirms Their Buy Rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

David Bailey

Morgan Stanley

$23.5→$24.63

Buy

7.09%

Upside

Reiterated

11/26/25

Analysts Are Bullish on These Healthcare Stocks: Fisher & Paykel Healthcare Corporation Limited (FSPKF), 3SBio (TRSBF)

Shane Storey

Canaccord Genuity

$25.02

Buy

8.77%

Upside

Reiterated

11/26/25

Canaccord Genuity Sticks to Their Buy Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Laura Sutcliffe

Citi

―

Hold

―

Reiterated

11/26/25

Analysts Offer Insights on Healthcare Companies: Nyxoah (NASDAQ: NYXH) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)

Craig Wong-Pan

RBC Capital

$19.31→$20.64

Sell

-10.28%

Downside

Reiterated

11/26/25

RBC Capital Sticks to Its Sell Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Christine Trinh

Macquarie

―

Buy

―

Reiterated

11/26/25

Macquarie Sticks to Their Buy Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Adrian Allbon

Jarden

―

Hold

―

Reiterated

11/26/25

Jarden Keeps Their Hold Rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Marcus Curley

UBS

―

Hold

―

Reiterated

11/26/25

Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA) and Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF)

David Low

J.P. Morgan

―

Hold

―

Reiterated

06/03/25

J.P. Morgan Sticks to Its Hold Rating for Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Vanessa Thomson

Jefferies

$23.83→$25.16

Buy

9.41%

Upside

Upgraded

05/28/25

Positive Report for Fisher & Paykel Healthcare Corporation Limited (FSPKF) from Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fisher & Paykel Healthcare Corporation Limited

1 Month

xxx

Success Rate

4/7 ratings generated profit

Average Return

+4.29%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +4.29% per trade.

3 Months

xxx

Success Rate

3/4 ratings generated profit

Average Return

+4.90%

reiterated a xxx

rating 14 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +4.90% per trade.

1 Year

Shane StoreyCanaccord Genuity

Success Rate

6/7 ratings generated profit

Average Return

+12.66%

reiterated a buy rating 19 days ago

Copying Shane Storey's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +12.66% per trade.

2 Years

xxx

Success Rate

6/7 ratings generated profit

Average Return

+12.66%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +12.66% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

FSPKF Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, FSPKF has received 5 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. FSPKF average Analyst price target in the past 3 months is 24.69.

Each month's total comprises the sum of three months' worth of ratings.

FSPKF Financial Forecast

FSPKF Earnings Forecast

The previous quarter’s earnings for FSPKF were $0.21.

FSPKF Sales Forecast

The previous quarter’s earnings for FSPKF were $652.67M.

FSPKF Stock Forecast FAQ

What is FSPKF’s average 12-month price target, according to analysts?

Based on analyst ratings, Fisher & Paykel Healthcare Corporation Limited’s 12-month average price target is 24.69.

What is FSPKF’s upside potential, based on the analysts’ average price target?

Fisher & Paykel Healthcare Corporation Limited has 7.35% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is FSPKF a Buy, Sell or Hold?

Fisher & Paykel Healthcare Corporation Limited has a consensus rating of Moderate Buy which is based on 4 buy ratings, 3 hold ratings and 1 sell ratings.

What is Fisher & Paykel Healthcare Corporation Limited’s price target?

The average price target for Fisher & Paykel Healthcare Corporation Limited is 24.69. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $28.49 ,the lowest forecast is $20.64. The average price target represents 7.35% Increase from the current price of $23.

What do analysts say about Fisher & Paykel Healthcare Corporation Limited?

Fisher & Paykel Healthcare Corporation Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of FSPKF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Stock Forecast & Price Target

FSPKF Analyst Ratings

FSPKF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Fisher & Paykel Healthcare Corporation Limited

FSPKF Analyst Recommendation Trends

FSPKF Financial Forecast

FSPKF Earnings Forecast

FSPKF Sales Forecast

FSPKF Stock Forecast FAQ

Detailed List of Analyst Forecasts